Literature DB >> 16313175

Electrostatic switches that mediate the pH-dependent conformational change of "short" recombinant human pseudocathepsin D.

Nathan E Goldfarb1, Minh T Lam, Arjo K Bose, Ambar M Patel, Alexander J Duckworth, Ben M Dunn.   

Abstract

Human cathepsin D (hCatD) is an aspartic peptidase with a low pH optimum. X-ray crystal structures have been solved for an active, low pH (pH 5.1) form (CatD(lo)) [Baldwin, E. T., Bhat, T. N., Gulnik, S., Hosur, M. V., Sowder, R. C., Cachau, R. E., Collins, J., Silva, A. M., and Erickson, J. W. (1993) Proc. Natl. Acad. Sci. U.S.A. 90, 6796-6800] and an inactive, high pH (pH 7.5) form (CatD(hi)) [Lee, A. Y., Gulnik, S. V., and Erickson, J. W. (1998) Nat. Struct. Biol. 5, 866-871]. It has been suggested that ionizable switches involving the carboxylate side chains of E5, E180, and D187 may mediate the reversible interconversion between CatD(hi) and CatD(lo) and that Y10 stabilizes CatD(hi) [Lee, A. Y., Gulnik, S. V., and Erickson, J. W. (1998) Nat. Struct. Biol. 5, 866-871]. To test these hypotheses, we generated single point mutants in "short" recombinant human pseudocathepsin D (srCatD), a model kinetically similar to hCatD [Beyer, B. M., and Dunn, B. M. (1996) J. Biol. Chem. 271, 15590-15596]. E180Q, Y10F, and D187N exhibit significantly higher kcat/Km values (2-, 3-, and 6-fold, respectively) at pH 3.7 and 4.75 compared to srCatD, indicating that these residues are important in stabilizing the CatD(hi). E5Q exhibits a 2-fold lower kcat/Km compared to srCatD at both pH values, indicating the importance of E5 in stabilizing the CatD(lo). Accordingly, full time-course "pH-jump" (pH 5.5-4.75) studies of substrate hydrolysis indicate that E180Q, D187N, and Y10F have shorter kinetic lag phases that represent the change from CatD(hi) to CatD(lo) compared to srCatD and E5Q. Intrinsic tryptophan fluorescence reveals that the variants have a native-like structure over the pH range of our assays. The results indicate that E180 and D187 participate as an electrostatic switch that initiates the conformational change of CatD(lo) to CatD(hi) and Y10 stabilizes CatD(hi) by hydrogen bonding to the catalytic Asp 33. E5 appears to play a less significant role as an ionic switch that stabilizes CatD(lo).

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16313175      PMCID: PMC2569848          DOI: 10.1021/bi0511686

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  24 in total

1.  Direct evidence of importance of lysosomes in degradation of intracellular proteins.

Authors:  R T Dean
Journal:  Nature       Date:  1975-10-02       Impact factor: 49.962

2.  Kinetic aspects of regulation of metabolic processes. The hysteretic enzyme concept.

Authors:  C Frieden
Journal:  J Biol Chem       Date:  1970-11-10       Impact factor: 5.157

3.  A mutated cathepsin-D devoid of its catalytic activity stimulates the growth of cancer cells.

Authors:  M Glondu; P Coopman; V Laurent-Matha; M Garcia; H Rochefort; E Liaudet-Coopman
Journal:  Oncogene       Date:  2001-10-18       Impact factor: 9.867

4.  The catalytic activity of pig pepsin C towards small synthetic substrates.

Authors:  C A Auffret; A P Ryle
Journal:  Biochem J       Date:  1979-04-01       Impact factor: 3.857

5.  Angiostatin generation by cathepsin D secreted by human prostate carcinoma cells.

Authors:  W Morikawa; K Yamamoto; S Ishikawa; S Takemoto; M Ono; J i Fukushi; S Naito; C Nozaki; S Iwanaga; M Kuwano
Journal:  J Biol Chem       Date:  2000-12-08       Impact factor: 5.157

6.  Characterization of new fluorogenic substrates for the rapid and sensitive assay of cathepsin E and cathepsin D.

Authors:  Y Yasuda; T Kageyama; A Akamine; M Shibata; E Kominami; Y Uchiyama; K Yamamoto
Journal:  J Biochem       Date:  1999-06       Impact factor: 3.387

7.  Defective acidification of intracellular organelles results in aberrant secretion of cathepsin D in cancer cells.

Authors:  Nina Kokkonen; Antti Rivinoja; Annika Kauppila; Marko Suokas; Ilmo Kellokumpu; Sakari Kellokumpu
Journal:  J Biol Chem       Date:  2004-07-16       Impact factor: 5.157

8.  Human cathepsin D.

Authors:  A J Barrett
Journal:  Adv Exp Med Biol       Date:  1977       Impact factor: 2.622

9.  Calculating proton uptake/release and binding free energy taking into account ionization and conformation changes induced by protein-inhibitor association: application to plasmepsin, cathepsin D and endothiapepsin-pepstatin complexes.

Authors:  Emil Alexov
Journal:  Proteins       Date:  2004-08-15

10.  Cathepsin-D affects multiple tumor progression steps in vivo: proliferation, angiogenesis and apoptosis.

Authors:  Guy Berchem; Murielle Glondu; Michel Gleizes; Jean-Paul Brouillet; Françoise Vignon; Marcel Garcia; Emmanuelle Liaudet-Coopman
Journal:  Oncogene       Date:  2002-08-29       Impact factor: 9.867

View more
  3 in total

1.  Neutralizing positive charges at the surface of a protein lowers its rate of amide hydrogen exchange without altering its structure or increasing its thermostability.

Authors:  Bryan F Shaw; Haribabu Arthanari; Max Narovlyansky; Armando Durazo; Dominique P Frueh; Michael P Pollastri; Andrew Lee; Basar Bilgicer; Steven P Gygi; Gerhard Wagner; George M Whitesides
Journal:  J Am Chem Soc       Date:  2010-11-19       Impact factor: 15.419

2.  Conformational dynamics of cathepsin D and binding to a small-molecule BACE1 inhibitor.

Authors:  Christopher R Ellis; Cheng-Chieh Tsai; Fang-Yu Lin; Jana Shen
Journal:  J Comput Chem       Date:  2017-04-02       Impact factor: 3.376

3.  Recombinant plasmepsin 1 from the human malaria parasite plasmodium falciparum: enzymatic characterization, active site inhibitor design, and structural analysis.

Authors:  Peng Liu; Melissa R Marzahn; Arthur H Robbins; Hugo Gutiérrez-de-Terán; David Rodríguez; Scott H McClung; Stanley M Stevens; Charles A Yowell; John B Dame; Robert McKenna; Ben M Dunn
Journal:  Biochemistry       Date:  2009-05-19       Impact factor: 3.162

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.